Post-IPO Equity - KalVista Pharmaceuticals - Dec 27, 2022 Funding Round Profile - Cointime

Bitcoin $98,881.32 +0.32%
Ethereum $3,320.47 -1.29%
BNB $630.32 +1.18%
Optimism $2.17 +4.28%
Arbitrum $0.80 +2.35%
Solana $255.42 -0.25%
Polygon $0.48 +8.25%
Cosmos $7.42 +15.70%
Avalanche $42.61 +19.49%

Bitcoin $98,881.32 +0.32%
Ethereum $3,320.47 -1.29%
BNB $630.32 +1.18%
Optimism $2.17 +4.28%
Arbitrum $0.80 +2.35%
Solana $255.42 -0.25%
Polygon $0.48 +8.25%
Cosmos $7.42 +15.70%
Avalanche $42.61 +19.49%

KalVista Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 58M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 23, 2011	Series A	£ 8M	Novo Holdings,SV Health Investors	Detail
Feb 10, 2021	Post-IPO Equity	$ 193.50M		Detail
Jul 22, 2015	Series B	$ 33M	Longwood Fund,Novo Holdings,etc.	Detail
Sep 6, 2015	IPO	$ 68M		Detail